A detailed history of Jane Street Group, LLC transactions in Rx Sight, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 51,747 shares of RXST stock, worth $2.53 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
51,747
Previous 20,303 154.87%
Holding current value
$2.53 Million
Previous $1.05 Million 197.33%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$50.42 - $64.29 $1.59 Million - $2.02 Million
31,444 Added 154.87%
51,747 $3.11 Million
Q1 2024

May 15, 2024

SELL
$35.51 - $57.92 $1.72 Million - $2.8 Million
-48,402 Reduced 70.45%
20,303 $1.05 Million
Q4 2023

Feb 14, 2024

BUY
$20.91 - $40.9 $1.44 Million - $2.81 Million
68,705 New
68,705 $2.77 Million
Q2 2023

Aug 14, 2023

BUY
$16.37 - $28.9 $889,873 - $1.57 Million
54,360 Added 313.86%
71,680 $2.06 Million
Q1 2023

May 15, 2023

BUY
$12.58 - $16.68 $217,885 - $288,897
17,320 New
17,320 $288,000

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $1.35B
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.